All posts by imreal

Top NYC Ankle and Foot Surgeon Dr. Stuart Mogul Re-launches his Website http://www.bunion.com


“My website www.bunion.com is a terrific resource to help educate those suffering from the condition. It informs them on what bunions are, treatments and procedures that can help,” says Dr. Stuart Mogul.

Stuart Mogul DPM, FACFAS, is an internationally recognized best-in-class foot surgeon, specializing in bunion surgery, who is in private practice on NYC’s Upper East Side. Dr. Mogul is pleased to announce the relaunch of his website, http://www.bunion.com, which he designed to help those suffering from painful, unattractive bunions. Knowledge is power, and http://www.bunion.com assists those suffering from bunions take the first step in finding relief. The user-friendly website offers both current and potential patients an easy-to-navigate site that focuses on the cause of bunions and treatment options available at Dr. Mogul’s state-of-the-art practice. As one of the top-rated foot surgeons in Manhattan, he offers treatment for many foot/ankle issues in addition to bunions including hammertoes, fractures, flat foot/flat feet, corns, neuromas and sports injuries. It is important that patients seek out a surgeon like Dr. Mogul who specializes in bunion surgery, not just foot, and ankle surgery. He has the ability to figure out what is causing each individual’s particular bunion and the experience to provide the customized treatment that’s right for them.

“My website http://www.bunion.com is a terrific resource to help educate those suffering from the condition. It informs them on what bunions are, treatments and procedures that can help,” says Dr. Stuart Mogul.

More About Dr. Stuart Mogul:

Dr. Stuart Mogul is a diplomate of The American Board of Foot & Ankle Surgery and a fellow of the American College of Foot and Ankle Surgeons. He is an attending physician at Lenox Hill Hospital, Midtown Surgical Center and The Center for Specialty Care in Manhattan, New York. Dr. Mogul treats many conditions at his clinic including Achilles tendon problems, ankle sprains, ankle instability, bunions, flat feet, foot fractures, gout, hammer toe, heel pain, ingrown toenails, plantar fasciitis, tendon injuries and more. At his successful clinic, located at 1111 Park Avenue Suite 1B in New York, NY, he practices free of the limitations mandated by in-network insurance participation and offers extended time, individualized attention and empathetic expertise. For more information or to schedule a consultation with Dr. Mogul, please visit http://www.bunion.com or http://www.footsurgerycenternyc.com or call (212) 658-1917.

Share article on social media or email:

Top NYC Otolaryngologist Dr. Gregory Levitin Has Developed a Unique, Needle-Free Approach to Successful Office Balloon Sinuplasty


News Image

“By performing a balloon sinuplasty in the office setting, I can improve a patient’s symptoms by 50 to 80% within the first week with no downtime or sedation using just topical anesthesia,” says Dr. Gregory Levitin.

Dr. Gregory Levitin performs over 100 in-office balloon sinuplasty procedures every year at his New York City-based office City Sinus Care. A relatively new technology, balloon sinuplasty is a quick and effective in-office treatment alternative to traditional sinus surgery performed under local anesthetic with minimal discomfort.

Dr. Levitin has recently developed an exclusive and unique topical anesthesia protocol that has eliminated 100% of needle injections for most cases. The purpose of balloon sinuplasty treatment is to provide relief from symptoms caused by chronic sinus and nasal inflammation by opening up the sinuses and nasal passages. By utilizing his needle-free approach, Dr. Levitin offers expertise in balloon sinuplasty that is truly revolutionary. Over the last 20 years, Dr. Levitin has found that the best solution is often the least invasive and by focusing exclusively on office-based nasal and sinus procedures, Dr. Levitin has been able to completely eliminate 100% of ENT surgery from his practice.

Many of the patients that Dr. Levitin treats have been suffering for months or even years. They are functional but just don’t feel normal. Only a small percentage of patients that come in need antibiotics, but nearly all have evidence of chronic inflammation. This accumulation of inflammation in the lining of the sinuses causes the most significant changes in patients’ quality of life, including difficulty breathing, sinus headaches and congestion. Dr. Levitin’s innovative, needle-free balloon sinuplasty is ideal for patients who suffer from chronic sinusitis or recurrent sinus infections, headaches or sinus pressure, chronic nasal obstruction or congestion, isolated sphenoid or frontal sinusitis, thick mucus discharge, or a reduced sense of smell or taste.

For those suffering from chronic sinusitis pain and discomfort and looking for a long-term solution, Dr. Levitin’s needle-free balloon sinuplasty may be just the answer. Unlike conventional sinus surgery, balloon sinuplasty does not include removal of bone or tissue from the nose or cause any changes to one’s appearance. During the office procedure, the sinus passages are widened with a balloon catheter that is inserted and inflated within the narrow nasal passages and then quickly removed. Without any incisions or tissue removal, there is also less bleeding, fewer risks, less post-operative pain and a quicker recovery time than with other surgical treatments.

“By performing a balloon sinuplasty in the office setting, I can improve a patient’s symptoms by 50 to 80% within the first week with no downtime or sedation using just topical anesthesia,” says Dr. Gregory Levitin. “After just two weeks, patients breathe better, sleep better, and most importantly feel better, and can finally get back their quality of life.”

More about Dr. Gregory Levitin:

Dr. Gregory Levitin, MD, FACS is a board certified Otolaryngologist-Head and Neck Surgeon and a Fellow of the American Academy of Otolaryngology (AAO-HNS). He is also an Associate Professor in the Department of Otolaryngology at The New York Eye and Ear Infirmary and is Director of the Vascular Birthmark Center of New York. Dr. Levitin’s areas of expertise include balloon sinuplasty, acute and chronic sinus disease, allergic rhinitis, snoring and obstructive sleep disorders, and voice disorders. For more information, please call 212-784-6643 to reach his Manhattan office at Columbus Circle, 200 W. 57th Street, Suite 1410, or visit http://www.sinusitistreatmentnyc.com.

Share article on social media or email:

Movemints, LLC Hits Milestone with 15 Million Mints Shipped Globally


News Image

“Movemints help clear aligner patients seat their trays, resulting in better fit, while increasing blood flow, fighting dry mouth, and freshening breath,” said Movemints Founder and Chief Executive Officer Dr. Dave Pechersky.

Movemints, LLC Hits Milestone with 15 Million Mints Shipped Globally

Movemints Promote Optimal Tooth Movement, Increase Blood Flow and Eliminate Dry Mouth During Clear Aligner Treatment

Movemints, LLC, which is dedicated to elevating the standard of care for clear aligner patients, announced today the company has shipped more than 15 million Movemints, which are the first and only concave shaped mints designed and formulated to promote optimal tooth movement during orthodontic therapy, to customers in more than 40 countries.

Developed by Orthodontist Dr. Dave Pechersky, Movemints offer a breakthrough treatment for clear aligner patients. They enable gentle chewing, which promotes optimal tooth movement, and increase blood flow, thereby reducing discomfort. Sweetened with a therapeutic dose of xylitol, Movemints eliminate dry mouth. The patented, sugar-free mints are comprised of five ingredients – xylitol, sorbitol, natural spearmint flavoring, natural mint flavoring, and magnesium stearate. Movemints are sold to dentists, orthodontists, and directly to patients through the dentalmovemints.com website as well as Amazon.com.

“Shipping 15 million mints to customers around the globe is a major milestone for Movemints, LLC and indicates that clear aligner patients globally recognize the benefits of chewing a Movemint,” said Dr. Dave, who today serves as the company’s Chief Executive Officer. “Movemints enable treatment progress and provide comfort during orthodontic therapy. They help clear aligner patients seat their trays, resulting in better fit, while increasing blood flow, fighting dry mouth, and freshening breath. We shipped our first Movemint in May 2018, and since then, have experienced exponential growth in mint distribution volume. We look forward to continuing to make the clear aligner journey an easier one for patients worldwide.”

About Movemints

Launched in 2018, Movemints fits the lifestyle of clear aligner patients, giving them fresh breath, more comfort, and delicious progress. The patented, concave shaped mints are first and only edible accessory designed and formulated for clear aligner patients. They offer a breakthrough treatment for gentle chewing, which promotes optimal tooth movement during orthodontic therapy, and can increase blood flow, thereby reducing discomfort. Sweetened with a therapeutic dose of xylitol, Movemints eliminate dry mouth. To date, Movemints, LLC has shipped more than 15 million mints to customers in more than 40 countries. The Pittsburgh-based company continues to experience a 30% year-over-year increase in mint distribution volume and international expansion. For more information, visit http://www.dentalmovemints.com or https://www.facebook.com/movemints.

Media Contact

Stacy Wagner, stacy@theprimaveragroup.com, 650-363-3509

# # #

Share article on social media or email:

MOBI CONNECT Products, Including Caregiver Monitoring and Support, Now Available In-Store at Walmart


News Image

With the rising costs and shortages of caregivers, and elderly abuse in some unfortunate cases, we wanted to offer an affordable solution to give family members peace of mind with our complete in-home monitoring network

MOBI Technologies, Inc., dedicated to building innovative Smart Health & Wellness products that are designed around the needs of individual users with relevance to modern living, is pleased to announce that three MOBI products are now available in-store at Walmart.

Walmart will carry MOBI’s Smart Emergency Alert Button, Smart Wireless Wi-Fi Otoscope and Smart DualScan Ear + Forehead Bluetooth Thermometer in over 4,500 stores across North America while MOBI CONNECT’s full line of products are available online at Walmart.com.

Every device within the MOBI CONNECT collection can be controlled from the MOBI SMART app and displayed on your mobile device, which is available for both iOS and Android. For a complete at home clinic, MOBI’s free app enables users to monitor & track their health in one place, using MOBI’s wide range of integrated health monitoring products.

The MOBI Smart Emergency Alert Button supports “aging in place” and brings family, friends, and caregivers peace-of-mind when not on site; allowing users to create a complete in-home monitoring network to notify friends and loved ones in an instant.

MOBI offers a variety of low-cost subscriptions to fit most budgets and can be expanded with other MOBI products for a complete 360 monitoring solution if needed. With one click, caregivers near or far can be alerted, and if required, professional support can dispatch emergency services.

“With the rising costs and shortages of caregivers, and elderly abuse in some unfortunate cases, we wanted to offer an affordable solution to give family members peace of mind with our complete in-home monitoring network,” said David Naghi, CEO of MOBI Technologies. “MOBI CONNECT allows elderly parents, relatives, or those with special needs to maintain independent living with simple, sophisticated tools that keep them connected from the comfort of their homes.”

The MOBI Smart Wireless Wi-Fi Otoscope allows users to easily view, record and track their inner ear, nose and throat in High Definition to share with family and healthcare professionals to help diagnose illness or injury.

The Smart DualScan Ear + Forehead Bluetooth Thermometer offers all the features, accuracy, and reliability you would expect from MOBI, including temperature and fever management using the MOBI app. With both ear and forehead reading methods and a bright, easy-to-read backlit display, the compact DualScan Bluetooth Thermometer meets your family’s needs perfectly.

For more information on all MOBI products, visit getmobi.com

About MOBI Technologies, Inc.

MOBI Technologies, Inc. is dedicated to build innovative and quality consumer electronics that are designed around the needs of individual users with relevance to modern living.

Share article on social media or email:

Family Source Consultants Hosts Free Webinar to Help Intended Parents Navigate the Affordable Care Act


News Image

With open enrollment just around the corner, it’s important to understand what your options are for maternity coverage if you are considering pursuing a surrogacy journey this year.

The Affordable Care Act: Intended Parent Questions Answered is a free on-demand webinar designed to help navigate hopeful moms and dads understand what to expect when using an ACA insurance plan for their surrogacy journey.

As a leading authority in gestational surrogacy, Family Source Consultants takes pride in assisting their Intended Parents through the more complicated matters of surrogacy insurance and medical coverage. IPs can access the webinar at their convenience and follow up with FSC when they choose.

Hosted by FSC Chief Business Development Officer Alan Osborne, the webinar covers the most cost-effective options for surrogate maternity coverage and the advantages and disadvantages of ACA plans. It is cohosted by the founder and president of International Fertility Insurance, Jason Smith, a regular speaker on surrogacy-related options and services, and a former IP himself. IFI specializes in assisting IPs through insurance matters.

Osborne says that the concept of maternity insurance can be challenging for IPs, and many don’t know where to start.

“I speak with a lot of intended parents who are confused about what insurance options are available for their surrogate,” he says. “With open enrollment just around the corner, it’s important to understand what your options are for maternity coverage if you are considering pursuing a surrogacy journey this year.”

Over the half-hour session, Osborne and Smith introduce parents to the ACA and answer common questions. They explain why the Affordable Care Act is the most cost-effective option and the various advantages and disadvantages in relation to a surrogacy journey.

Smith gives examples of nuances within ACA in terms of exclusion, caps, deductibles, and copays, and how these contributed to the overall costs of a surrogacy arrangement. He also reminded IPs that insurance criteria and policy dates can vary between states and countries.

Intended Parents should know that the right insurance plan is crucial. Understandably, many IPs are eager to find an affordable maternity insurance solution. Purchasing an ACA insurance plan is one of the most cost-effective ways of providing surrogate maternity coverage throughout the year, especially if you’re considering a multiple-embryo transfer.

The webinar is now available for viewing on-demand at https://www.familysourceconsultants.com/about-us/media/webinars/.

Open Enrollment for 2023 runs from November 1, 2022, to January 15, 2023. Those with questions regarding surrogate maternity insurance or other matters relating to surrogacy are invited to contact Family Source Consultants.

Share article on social media or email:

Kalamazoo Valley Adds Medical Cannabis Courses to Its Cannabis Education Program


“There is so much confusion about what medical cannabis is and how to use it,” said Medical Cannabis Mentor Founder and CEO Joe Dolce.

Expanding on its popular workforce cannabis training program, Kalamazoo Valley Community College today announced that it will offer an online medical cannabis education course.

Through a unique partnership with Medical Cannabis Mentor, a leader in online medical cannabis education, Kalamazoo Valley will offer Cannabis Therapeutics 2022, an in-depth, foundational self-paced course for healthcare providers, dispensary personnel and patients. Kalamazoo Valley is Medical Cannabis Mentor’s first community college partner.

“Through conversations with community members and patients, we learned there was a lack of formal and easily accessible education for understanding the various therapeutic components of cannabis,” said Craig Jbara, vice president for strategic and business development at Kalamazoo Valley. “We believe it is important to promote accurate information and, if appropriate, provide an opportunity for improved quality of life in our community.”

The college will begin offering the self-paced, online training starting today, Oct. 24. The certificate program costs $299 and should take between eight to 10 hours to complete.

“There is so much confusion about what medical cannabis is and how to use it,” said Medical Cannabis Mentor Founder and CEO Joe Dolce. “That’s why our mission is ‘Education Before Medication.’ The goal is to separate myth from fact and to bring professionals and patients up to speed quickly. Our materials are based on the latest research and data from the world’s leading scientists and clinicians.”

After the successful completion of the virtual training units, participants will earn a certificate of completion from Kalamazoo Valley Community College and Medical Cannabis Mentors.

Medical Cannabis Mentor online programs are evidence-based and have been vetted and approved by healthcare professions and health agencies, such as New York’s Department of Health.

For more information, visit http://www.kvcc.edu/cannabis.

Share article on social media or email:

Echosens and ChronWell Announce Exclusive Strategic Partnership Between FibroScan and LIVErHEALTHY to Improve Patient Outcomes and Cost Savings


News Image

“NAFLD and NASH remain a silent and dangerous epidemic for over 80 million Americans. We are proud to partner with Echosens to offer healthcare providers and payers a scalable and cost-effective way to identify and treat those suffering from this alarming condition.” Joe Rubinsztain, CEO, ChronWell.

Echosens North America, a high-technology company offering the FibroScan® portfolio of solutions, and ChronWell, a digital health and therapeutics company targeting metabolic conditions like non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), today announce an exclusive strategic partnership to offer LIVErHEALTHY™ in conjunction with FibroScan. Under this exclusive agreement, Echosens and ChronWell will expand digital collaboration between their platforms and co-promote FibroScan and LIVErHEALTHY, respectively, as the preferred non-invasive testing and digital therapeutic platform for NAFLD and NASH.

“NAFLD and NASH remain a silent and dangerous epidemic for over 80 million Americans,” says Joe Rubinsztain, CEO, ChronWell. “We are proud to partner with Echosens to offer healthcare providers and payers a scalable and cost-effective way to identify and treat those suffering from this alarming condition.”

NAFLD, a common metabolic liver disease caused by fat accumulation in the liver, and its more severe form NASH, are ‘silent’ diseases and asymptomatic in their early stages. As a result, many go undiagnosed. Between 5-12% of people with NASH will progress to cirrhosis, late-stage scarring in the liver. Liver damage from cirrhosis generally can’t be reversed unless diagnosed and treated earlier in the disease progression.

“This strategic partnership is a powerful combination that reflects our collective commitment to ending the epidemic of fatty liver disease and halting the progression of NAFLD/NASH,” says Jon Gingrich, CEO of Echosens North America. “LIVErHEALTHY complements our FibroScan platform, which includes solutions for hospitals, clinics, and private practices. Together, these important tools will support liver programs to ultimately improve patient outcomes.”

The risk of progression to advanced liver disease, including liver cancer, is higher in people with NASH than in the general population, and NASH is predicted to be the leading cause of liver transplantation by 2030. Moreover, NASH increases the risk of developing cardiovascular disease. Currently, no treatment is globally approved for the treatment of NASH, and patients with NASH are left with very few management options.

“Early assessment, detection and monitoring of liver disease hold the key to preventing this disease,” Gingrich continues. “Working collaboratively with our partners, we can demonstrate to payers, employers and other entities at risk for the cost of healthcare, that LIVErHEALTHY plus FibroScan is a cost-effective approach to diagnosing and treating NAFLD/NASH. With shared dedication and alignment to value-based care, we look forward to supporting the marketplace as it prepares for the entry of specialty pharmaceuticals.”

About Echosens

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 3,500 peer-reviewed publications and 160 international guidelines. Examinations are covered by Medicare, Medicaid and many insurance plans. For more information, please visit https://www.echosens.com/.

About ChronWell

ChronWell is a digital health and therapeutics company targeting metabolic conditions like NAFLD and NASH through LIVErHEALTHY™, its digital health platform. ChronWell offers healthcare providers and payors a highly automated, scalable and profitable solution to detect and manage NAFLD using clinical best-practices in partnership with the leading diagnostic and therapeutic leaders in the field. For more information, follow us on LinkedIn or visit chronwell.com.

Share article on social media or email:

Michael Wilkerson releases new book Why America Matters


News Image

Why America Matters confronts the most challenging questions facing our nation today and points the way towards an American renaissance.

While exploring the meaning of American exceptionalism in a postmodern, post-exceptional world, Wilkerson unpacks the cultural phenomena that have defined our generation, all within the historical context and framework of the unique American experiment: the foundational ideas of life, liberty, and the pursuit of happiness. Wilkerson’s first book, Stormwall, anticipated looming inflation and identified the crisis in American democracy leading up to the 2020 election. Why America Matters picks up where Stormwall left off, revealing not just the multiple crises facing the nation, but importantly prescribing real solutions relevant for all Americans.

“I wrote this book to remind us of forgotten truths about America’s meaning, and about our country’s role in the world,” said Wilkerson. “I want to breathe hope and life into this great nation’s future, which can only be done by understanding our past—with its successes and failures. Why America Matters confirms that it’s not too late to find a way forward amidst a growing struggle for the soul and future of the only place we Americans have to call home.”

Wilkerson has written for The American Conservative, American Greatness, The American Spectator, Barron’s, The Epoch Times, The Hill, Jackson Hole Economics, and Marketwatch, among others. He was the Chief Executive Officer of Fairfax Africa Holdings Corporation, a leading emerging markets investment firm, and previously served as Managing Director at Lazard, one of the world’s preeminent financial advisory and asset management firms. Wilkerson is chairman of charity: water, a nonprofit organization bringing clean and safe water to people around the world. He holds an MBA from Harvard Business School, an MA in International Relations from Yale University, and a BS from Oral Roberts University.

Please visit http://www.whyamericamatters.com for more information on the book, and http://www.stormwall.com for more information on Wilkerson, his writings, and his passions.

Share article on social media or email:

MEDIA ALERT — Addressing the Opioid Crisis; Baltimore to Host AATOD 2022, Global Gathering of Policy Makers, Experts


When: Sunday, October 30 through Thursday, November 3, 2022

Where: Baltimore Hilton Inner Harbor, 401 W. Pratt Street, Baltimore, MD 21201 What: American Association for the Treatment of Opioid Dependence (AATOD) 2022 Conference: “The Power of Collaboration”

Co-hosted by: Opioid Treatment Providers of Maryland and the Maryland Department of Health — Behavioral Health Administration.


  • Speakers include the Director of the White House Office of National Drug Control Policy Dr. Rahul Gupta and HHS Assistant Secretary for Mental Health and Substance Use and the Leader of SAMHSA Miriam Delphin-Rittmon, Ph.D.

Why: The U.S. recently passed the benchmark of 100,000 deaths over a 12-month period from accidental drug overdose (OD). COVID-19 brought about several temporary changes to the way medication-assisted treatment (MAT) for opioid use disorder (OUD), including methadone administration, is provided to patients through our nation’s opioid treatment programs (OTPs). Currently, there is widespread discussion and controversy about what changes should be made permanent and what other changes should be considered.

VIP Speaker Highlights — Open to News Media:

  • Tuesday, November 1: 8:45 AM – 10:15 AM – Opening Plenary. Robin E. Rickard, JD, Executive Director, Opioid Operational Command Center, Crownsville, MD; Mark W. Parrino, M.P.A., President, AATOD; Rahul Gupta, MD, MPH, MBA, FACP, Director of the White House Office of National Drug Control Policy (ONDCP). Moderated by Kenneth B. Stoller, MD, DLFAPA, Director, Johns Hopkins Broadway Center for Addiction; Associate Professor, Department of Psychiatry, Johns Hopkins University School of Medicine.
  • Wednesday, November 2: 9:15 AM – 10:45 AM – Middle Plenary. Kathleen Rebbert-Franklin, LCSW-C, Director, Service Access and Practice Innovation, Maryland Department of Health, Behavioral Health Administration, Catonsville, MD(advanced scheduling requested); Babak Imanoel, DO, Medical Director, Northern Parkway Treatment Services, Baltimore, MD; Gregory Branch, MD, MBA, CPE, Health Officer, and Director, Baltimore, MD. Moderated by Vickie Walters, LCSW-C, Executive Director, Institutes for Behavior Resources, Inc, Baltimore, MD.
  • Thursday, November 3: 11:45 AM – 1:00 PM – Closing Plenary. Miriam E. Delphin-Rittmon, Ph.D., the HHS Assistant Secretary for Mental Health and Substance Use and the leader of the Substance Abuse and Mental Health Services Administration (SAMHSA). Moderated by Mark Parrino/AATOD.

Call in advance to secure onsite interviews; same-day requests honored as possible. Media are encouraged to cover all workshops, hot topic roundtables, and plenary sessions but will not be attending preconference sessions, invitation-only events, or any meetings specifically closed to the public. Press encouraged to pre-register. #aatod2022

Share article on social media or email:

Spend Matters recognizes low-code based Kissflow’s Procurement Cloud in its “50 to Watch” List


News Image

This recognition further validates our commitment to evolve and offer simple and innovative procurement solutions.

Kissflow’s Procurement Cloud, a flexible source-to-pay software solution provider today announced its recognition on the Spend Matters “50 to Watch” 2022 list. The list highlights innovative procurement and supply chain solutions that demonstrate fast-paced growth and momentum.

Kissflow’s Procurement Cloud enables businesses of all sizes to streamline their procurement processes by embracing the low-code/no-code paradigm. Its modules include eProcurement, Punchout Catalogs, AP Automation, Supplier Portal, Supplier Management, Inventory Management, Expense Management, and Custom Integrations.

The Spend Matters “50 to Watch” list recognizes the fast-rising companies in the procurement and supply chain market. Vendors listed are independently selected by the analyst team over multiple rounds of debate, focusing on factors such as growth, innovation, tech capabilities, and solution delivery.

“Kissflow Procurement Cloud covers all P2P functionalities, from purchasing requisition, purchase orders and receiving to invoice reception and approval,” said Xavier Olivera, Lead Analyst & Editor, Spend Matters. “In addition to core P2P functionalities, KPC offers capabilities around vendor management, contract approvals, data analytics and systems integrations. KPC offers a combination of P2P cloud-based software enhanced with a platform-as-a-service model that allows the integration of third-party apps.”

“We are delighted to be part of Spend Matters’ 2022 “50 to Watch” list. The procurement landscape has been going through a massive transformation, induced by the pandemic. Procurement experts are facing the heat in adapting to the growing digital business demands. They want flexible solutions which can be customized to their specific needs. This recognition further validates our commitment to evolve and offer simple and innovative procurement solutions,” said Prasanna Rajendran, Head of Business, Kissflow’s Procurement Cloud.

Kissflow’s Procurement Cloud is the first stand-alone application built on the Kissflow low-code/no-code work platform.

About Kissflow’s Procurement Cloud

Kissflow’s Procurement Cloud is a cloud-based flexible source-to-pay software that enables businesses of all sizes to streamline their procurement processes. Its modules include procure-to-pay, supplier management, purchase invoicing, analytics, and integrations, all in one unified platform.

KPC’s USP is an end-to-end P2P cloud-based software that can be completely customized to fit business needs. Served as a platform-as-a-service model, the product can be best utilized by integrating it with third-party applications. Learn more about the procurement cloud offering, please visit https://kissflow.com/procurement/.

About Spend Matters

Spend Matters is the leading solution intelligence source for procurement and supply chain professionals. Combining deep technology analysis and tailored advisory services with daily news coverage and subscription research, Spend Matters is trusted by CPOs, consultants, investors and solution providers alike as their procurement technology intelligence partner.

Share article on social media or email: